Shattuck Labs Secures $54.9M from Warrant Exercises, Bolstering Cash Position
STTK has more than doubled off its 52-week low of $0.712 on elevated volume (8.9× avg).
Summary
Shattuck Labs announced it received notices for the exercise of 50.6 million common stock warrants, generating $54.9 million in gross proceeds. This capital infusion significantly boosts the company's liquidity. While the company previously indicated in its May 7th 10-Q that warrant exercises contributed to extending its cash runway into 2029, this announcement provides the specific financial details of those exercises. The $54.9 million is a material amount, representing approximately 18% of the company's market capitalization.
At the time of this announcement, STTK was trading at $3.95 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $299.1M. The 52-week trading range was $0.71 to $8.33. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Reuters.